25 XP   0   0   10

Brooks Laboratories Limited
Buy, Hold or Sell?

Let's analyse Brooks Laboratories Limited together

PenkeI guess you are interested in Brooks Laboratories Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Brooks Laboratories Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Brooks Laboratories Limited

I send you an email if I find something interesting about Brooks Laboratories Limited.

Quick analysis of Brooks Laboratories Limited (30 sec.)










What can you expect buying and holding a share of Brooks Laboratories Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR28.18
Expected worth in 1 year
INR-63.82
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
INR-92.00
Return On Investment
-87.8%

For what price can you sell your share?

Current Price per Share
INR104.80
Expected price per share
INR87.10 - INR140.00
How sure are you?
50%

1. Valuation of Brooks Laboratories Limited (5 min.)




Live pricePrice per Share (EOD)

INR104.80

Intrinsic Value Per Share

INR-101.67 - INR-60.76

Total Value Per Share

INR-73.49 - INR-32.58

2. Growth of Brooks Laboratories Limited (5 min.)




Is Brooks Laboratories Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$8.8m$16.1m-$7.2m-81.6%

How much money is Brooks Laboratories Limited making?

Current yearPrevious yearGrowGrow %
Making money-$2.5m-$2.3m-$190.5k-7.6%
Net Profit Margin-33.1%-21.4%--

How much money comes from the company's main activities?

3. Financial Health of Brooks Laboratories Limited (5 min.)




What can you expect buying and holding a share of Brooks Laboratories Limited? (5 min.)

Welcome investor! Brooks Laboratories Limited's management wants to use your money to grow the business. In return you get a share of Brooks Laboratories Limited.

What can you expect buying and holding a share of Brooks Laboratories Limited?

First you should know what it really means to hold a share of Brooks Laboratories Limited. And how you can make/lose money.

Speculation

The Price per Share of Brooks Laboratories Limited is INR104.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Brooks Laboratories Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Brooks Laboratories Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR28.18. Based on the TTM, the Book Value Change Per Share is INR-23.00 per quarter. Based on the YOY, the Book Value Change Per Share is INR21.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Brooks Laboratories Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.10-0.1%-0.10-0.1%-0.07-0.1%-0.09-0.1%-0.040.0%
Usd Book Value Change Per Share-0.28-0.3%-0.28-0.3%0.250.2%-0.040.0%-0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.28-0.3%-0.28-0.3%0.250.2%-0.040.0%-0.010.0%
Usd Price Per Share0.75-0.75-0.87-0.64-0.75-
Price to Earnings Ratio-7.83--7.83--11.82--7.82-19.64-
Price-to-Total Gains Ratio-2.71--2.71-3.47--5.73-4.33-
Price to Book Ratio2.21-2.21-1.42-1.48-1.53-
Price-to-Total Gains Ratio-2.71--2.71-3.47--5.73-4.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.2576
Number of shares795
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.28-0.04
Usd Total Gains Per Share-0.28-0.04
Gains per Quarter (795 shares)-219.42-29.46
Gains per Year (795 shares)-877.67-117.82
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-878-8880-118-128
20-1755-17660-236-246
30-2633-26440-353-364
40-3511-35220-471-482
50-4388-44000-589-600
60-5266-52780-707-718
70-6144-61560-825-836
80-7021-70340-943-954
90-7899-79120-1060-1072
100-8777-87900-1178-1190

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%4.06.00.040.0%8.06.00.057.1%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%4.06.00.040.0%8.06.00.057.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.014.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%4.06.00.040.0%8.06.00.057.1%

Fundamentals of Brooks Laboratories Limited

About Brooks Laboratories Limited

Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. It offers liquid and dry powder injection, carbapenem drugs, tablets, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2024-04-20 02:10:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Brooks Laboratories Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Brooks Laboratories Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Brooks Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -33.1% means that ₹-0.33 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Brooks Laboratories Limited:

  • The MRQ is -33.1%. The company is making a huge loss. -2
  • The TTM is -33.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-33.1%TTM-33.1%0.0%
TTM-33.1%YOY-21.4%-11.6%
TTM-33.1%5Y-28.4%-4.7%
5Y-28.4%10Y-13.0%-15.3%
1.1.2. Return on Assets

Shows how efficient Brooks Laboratories Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Brooks Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • -19.1% Return on Assets means that Brooks Laboratories Limited generated ₹-0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Brooks Laboratories Limited:

  • The MRQ is -19.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -19.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.1%TTM-19.1%0.0%
TTM-19.1%YOY-9.9%-9.2%
TTM-19.1%5Y-13.0%-6.0%
5Y-13.0%10Y-5.3%-7.7%
1.1.3. Return on Equity

Shows how efficient Brooks Laboratories Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Brooks Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • -28.3% Return on Equity means Brooks Laboratories Limited generated ₹-0.28 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Brooks Laboratories Limited:

  • The MRQ is -28.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -28.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-28.3%TTM-28.3%0.0%
TTM-28.3%YOY-30.6%+2.4%
TTM-28.3%5Y-24.4%-3.8%
5Y-24.4%10Y-10.9%-13.5%

1.2. Operating Efficiency of Brooks Laboratories Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Brooks Laboratories Limited is operating .

  • Measures how much profit Brooks Laboratories Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Brooks Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -57.8% means the company generated ₹-0.58  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Brooks Laboratories Limited:

  • The MRQ is -57.8%. The company is operating very inefficient. -2
  • The TTM is -57.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-57.8%TTM-57.8%0.0%
TTM-57.8%YOY-23.8%-34.1%
TTM-57.8%5Y-24.8%-33.1%
5Y-24.8%10Y-10.8%-13.9%
1.2.2. Operating Ratio

Measures how efficient Brooks Laboratories Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.53 means that the operating costs are ₹1.53 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Brooks Laboratories Limited:

  • The MRQ is 1.529. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.529. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.529TTM1.5290.000
TTM1.529YOY1.242+0.287
TTM1.5295Y1.242+0.287
5Y1.24210Y1.113+0.129

1.3. Liquidity of Brooks Laboratories Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Brooks Laboratories Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.83 means the company has ₹0.83 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Brooks Laboratories Limited:

  • The MRQ is 0.833. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.833. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.833TTM0.8330.000
TTM0.833YOY1.252-0.419
TTM0.8335Y0.867-0.034
5Y0.86710Y1.242-0.375
1.3.2. Quick Ratio

Measures if Brooks Laboratories Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Brooks Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.47 means the company can pay off ₹0.47 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Brooks Laboratories Limited:

  • The MRQ is 0.469. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.469. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.469TTM0.4690.000
TTM0.469YOY0.684-0.215
TTM0.4695Y0.479-0.010
5Y0.47910Y0.813-0.334

1.4. Solvency of Brooks Laboratories Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Brooks Laboratories Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Brooks Laboratories Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.33 means that Brooks Laboratories Limited assets are financed with 32.5% credit (debt) and the remaining percentage (100% - 32.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Brooks Laboratories Limited:

  • The MRQ is 0.325. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.325. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.325TTM0.3250.000
TTM0.325YOY0.314+0.011
TTM0.3255Y0.380-0.055
5Y0.38010Y0.305+0.075
1.4.2. Debt to Equity Ratio

Measures if Brooks Laboratories Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Brooks Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 48.2% means that company has ₹0.48 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Brooks Laboratories Limited:

  • The MRQ is 0.482. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.482. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.482TTM0.4820.000
TTM0.482YOY0.977-0.495
TTM0.4825Y0.742-0.260
5Y0.74210Y0.524+0.217

2. Market Valuation of Brooks Laboratories Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Brooks Laboratories Limited generates.

  • Above 15 is considered overpriced but always compare Brooks Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -7.83 means the investor is paying ₹-7.83 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Brooks Laboratories Limited:

  • The EOD is -13.161. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.830. Based on the earnings, the company is expensive. -2
  • The TTM is -7.830. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.161MRQ-7.830-5.331
MRQ-7.830TTM-7.8300.000
TTM-7.830YOY-11.820+3.990
TTM-7.8305Y-7.820-0.010
5Y-7.82010Y19.639-27.459
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Brooks Laboratories Limited:

  • The EOD is -18.389. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.940. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.940. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-18.389MRQ-10.940-7.449
MRQ-10.940TTM-10.9400.000
TTM-10.940YOY-2.941-7.999
TTM-10.9405Y-36.058+25.118
5Y-36.05810Y-25.086-10.972
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Brooks Laboratories Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.21 means the investor is paying ₹2.21 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Brooks Laboratories Limited:

  • The EOD is 3.719. Based on the equity, the company is fair priced.
  • The MRQ is 2.213. Based on the equity, the company is underpriced. +1
  • The TTM is 2.213. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.719MRQ2.213+1.507
MRQ2.213TTM2.2130.000
TTM2.213YOY1.425+0.788
TTM2.2135Y1.483+0.730
5Y1.48310Y1.528-0.045
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Brooks Laboratories Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---23.000-23.0000%21.020-209%-3.088-87%-1.198-95%
Book Value Per Share--28.17628.1760%51.176-45%37.413-25%40.966-31%
Current Ratio--0.8330.8330%1.252-33%0.867-4%1.242-33%
Debt To Asset Ratio--0.3250.3250%0.314+3%0.380-14%0.305+6%
Debt To Equity Ratio--0.4820.4820%0.977-51%0.742-35%0.524-8%
Dividend Per Share----0%-0%-0%-0%
Eps---7.963-7.9630%-6.167-23%-7.288-8%-3.065-62%
Free Cash Flow Per Share---5.699-5.6990%-24.785+335%-7.548+32%-5.903+4%
Free Cash Flow To Equity Per Share---1.350-1.3500%-0.374-72%-0.535-60%-1.526+13%
Gross Profit Margin--1.0161.0160%1.013+0%1.0200%0.736+38%
Intrinsic Value_10Y_max---60.759--------
Intrinsic Value_10Y_min---101.669--------
Intrinsic Value_1Y_max---5.957--------
Intrinsic Value_1Y_min---10.383--------
Intrinsic Value_3Y_max---17.998--------
Intrinsic Value_3Y_min---31.213--------
Intrinsic Value_5Y_max---30.161--------
Intrinsic Value_5Y_min---51.900--------
Market Cap2750654160.000+41%1636481745.0001636481745.0000%1913384430.000-14%1393174836.000+17%1634513242.500+0%
Net Profit Margin---0.331-0.3310%-0.214-35%-0.284-14%-0.130-61%
Operating Margin---0.578-0.5780%-0.238-59%-0.248-57%-0.108-81%
Operating Ratio--1.5291.5290%1.242+23%1.242+23%1.113+37%
Pb Ratio3.719+41%2.2132.2130%1.425+55%1.483+49%1.528+45%
Pe Ratio-13.161-68%-7.830-7.8300%-11.820+51%-7.8200%19.639-140%
Price Per Share104.800+41%62.35062.3500%72.900-14%53.080+17%62.275+0%
Price To Free Cash Flow Ratio-18.389-68%-10.940-10.9400%-2.941-73%-36.058+230%-25.086+129%
Price To Total Gains Ratio-4.557-68%-2.711-2.7110%3.468-178%-5.726+111%4.331-163%
Quick Ratio--0.4690.4690%0.684-31%0.479-2%0.813-42%
Return On Assets---0.191-0.1910%-0.099-48%-0.130-32%-0.053-72%
Return On Equity---0.283-0.2830%-0.306+8%-0.244-14%-0.109-61%
Total Gains Per Share---23.000-23.0000%21.020-209%-3.088-87%-1.198-95%
Usd Book Value--8874384.0008874384.0000%16118352.000-45%11783704.800-25%12902687.472-31%
Usd Book Value Change Per Share---0.276-0.2760%0.252-209%-0.037-87%-0.014-95%
Usd Book Value Per Share--0.3380.3380%0.614-45%0.449-25%0.492-31%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.096-0.0960%-0.074-23%-0.087-8%-0.037-62%
Usd Free Cash Flow---1794972.000-1794972.0000%-7806360.000+335%-2377327.200+32%-1859363.222+4%
Usd Free Cash Flow Per Share---0.068-0.0680%-0.297+335%-0.091+32%-0.071+4%
Usd Free Cash Flow To Equity Per Share---0.016-0.0160%-0.004-72%-0.006-60%-0.018+13%
Usd Market Cap33007849.920+41%19637780.94019637780.9400%22960613.160-14%16718098.032+17%19614158.910+0%
Usd Price Per Share1.258+41%0.7480.7480%0.875-14%0.637+17%0.747+0%
Usd Profit---2508024.000-2508024.0000%-2317512.000-8%-2370472.800-5%-999431.477-60%
Usd Revenue--7584552.0007584552.0000%10811208.000-30%8508681.600-11%8619250.886-12%
Usd Total Gains Per Share---0.276-0.2760%0.252-209%-0.037-87%-0.014-95%
 EOD+5 -3MRQTTM+0 -0YOY+8 -265Y+10 -2410Y+11 -23

3.2. Fundamental Score

Let's check the fundamental score of Brooks Laboratories Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-13.161
Price to Book Ratio (EOD)Between0-13.719
Net Profit Margin (MRQ)Greater than0-0.331
Operating Margin (MRQ)Greater than0-0.578
Quick Ratio (MRQ)Greater than10.469
Current Ratio (MRQ)Greater than10.833
Debt to Asset Ratio (MRQ)Less than10.325
Debt to Equity Ratio (MRQ)Less than10.482
Return on Equity (MRQ)Greater than0.15-0.283
Return on Assets (MRQ)Greater than0.05-0.191
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Brooks Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.235
Ma 20Greater thanMa 50103.315
Ma 50Greater thanMa 100111.745
Ma 100Greater thanMa 200127.479
OpenGreater thanClose104.800
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets1,095,973
Total Liabilities356,441
Total Stockholder Equity739,532
 As reported
Total Liabilities 356,441
Total Stockholder Equity+ 739,532
Total Assets = 1,095,973

Assets

Total Assets1,095,973
Total Current Assets275,063
Long-term Assets819,910
Total Current Assets
Cash And Cash Equivalents 232
Short-term Investments 13,550
Net Receivables 127,542
Inventory 113,032
Other Current Assets 20,707
Total Current Assets  (as reported)275,063
Total Current Assets  (calculated)275,063
+/-0
Long-term Assets
Property Plant Equipment 148,089
Intangible Assets 1,988
Other Assets 1,000
Long-term Assets  (as reported)819,910
Long-term Assets  (calculated)151,077
+/- 668,833

Liabilities & Shareholders' Equity

Total Current Liabilities330,213
Long-term Liabilities26,228
Total Stockholder Equity739,532
Total Current Liabilities
Short-term Debt 59,100
Short Long Term Debt 56,635
Accounts payable 233,704
Other Current Liabilities 11,444
Total Current Liabilities  (as reported)330,213
Total Current Liabilities  (calculated)360,883
+/- 30,670
Long-term Liabilities
Long term Debt Total 6,022
Other Liabilities 20,205
Long-term Liabilities  (as reported)26,228
Long-term Liabilities  (calculated)26,227
+/- 1
Total Stockholder Equity
Common Stock247,028
Retained Earnings -191,008
Accumulated Other Comprehensive Income 3,510
Capital Surplus 680,003
Total Stockholder Equity (as reported)739,532
Total Stockholder Equity (calculated)739,533
+/- 1
Other
Capital Stock247,028
Cash And Equivalents232
Cash and Short Term Investments 13,782
Common Stock Shares Outstanding 24,945
Current Deferred Revenue25,965
Liabilities and Stockholders Equity 1,095,973
Net Debt 64,890
Net Invested Capital 796,167
Net Tangible Assets 737,545
Net Working Capital -55,150
Property Plant and Equipment Gross 148,089
Short Long Term Debt Total 65,122



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-31
> Total Assets 
253,814
321,188
372,567
408,638
1,058,030
1,316,598
1,404,378
1,351,447
1,525,367
1,630,918
1,726,647
1,679,509
1,578,639
1,620,773
1,959,105
1,095,973
1,095,9731,959,1051,620,7731,578,6391,679,5091,726,6471,630,9181,525,3671,351,4471,404,3781,316,5981,058,030408,638372,567321,188253,814
   > Total Current Assets 
160,584
149,824
178,498
206,944
405,830
659,379
696,803
547,826
325,315
240,083
296,482
319,628
379,179
478,014
611,820
275,063
275,063611,820478,014379,179319,628296,482240,083325,315547,826696,803659,379405,830206,944178,498149,824160,584
       Cash And Cash Equivalents 
52,258
21,998
8,583
8,712
186,839
238,718
299,882
229,228
22,258
18,368
6,455
24,939
3,960
8,839
26,050
232
23226,0508,8393,96024,9396,45518,36822,258229,228299,882238,718186,8398,7128,58321,99852,258
       Short-term Investments 
0
200
200
0
0
0
0
0
0
2,594
3,222
-75,155
11,318
12,567
-2,196
13,550
13,550-2,19612,56711,318-75,1553,2222,5940000002002000
       Net Receivables 
0
0
0
0
0
0
179,264
239,741
182,849
114,675
167,623
191,978
237,429
227,458
312,741
127,542
127,542312,741227,458237,429191,978167,623114,675182,849239,741179,264000000
       Inventory 
46,980
34,709
47,258
55,017
51,601
49,826
60,287
75,339
66,890
76,990
114,091
100,534
137,749
236,031
275,224
113,032
113,032275,224236,031137,749100,534114,09176,99066,89075,33960,28749,82651,60155,01747,25834,70946,980
       Other Current Assets 
61,346
92,917
122,457
143,215
167,390
370,835
336,634
243,259
236,167
144,725
172,714
2,177
41
5,686
1
20,707
20,70715,686412,177172,714144,725236,167243,259336,634370,835167,390143,215122,45792,91761,346
   > Long-term Assets 
93,231
171,364
194,069
201,693
652,200
657,219
707,575
803,621
1,200,052
1,390,835
1,430,165
1,359,883
1,199,461
1,142,758
1,347,282
819,910
819,9101,347,2821,142,7581,199,4611,359,8831,430,1651,390,8351,200,052803,621707,575657,219652,200201,693194,069171,36493,231
       Property Plant Equipment 
92,981
171,197
193,986
197,196
420,314
561,696
573,112
691,810
1,034,247
1,185,896
1,245,321
1,171,720
1,128,520
1,077,017
1,244,901
148,089
148,0891,244,9011,077,0171,128,5201,171,7201,245,3211,185,8961,034,247691,810573,112561,696420,314197,196193,986171,19792,981
       Long Term Investments 
0
0
0
0
0
0
200
200
200
200
200
200
0
0
0
0
0000200200200200200200000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
3,691
2,803
6,880
6,306
1,988
1,9886,3066,8802,8033,69100000000000
       Long-term Assets Other 
250
166
83
4,498
231,886
95,523
134,462
111,811
165,805
204,939
80,469
-2
-1
-1,087,174
79,745
-792,022
-792,02279,745-1,087,174-1-280,469204,939165,805111,811134,46295,523231,8864,49883166250
> Total Liabilities 
204,704
235,820
236,148
214,365
145,397
262,527
281,471
237,279
304,868
390,852
581,924
628,003
594,480
829,289
615,909
356,441
356,441615,909829,289594,480628,003581,924390,852304,868237,279281,471262,527145,397214,365236,148235,820204,704
   > Total Current Liabilities 
81,182
75,179
117,939
127,702
133,270
243,155
259,434
217,372
279,216
248,245
398,497
474,611
457,991
637,142
488,783
330,213
330,213488,783637,142457,991474,611398,497248,245279,216217,372259,434243,155133,270127,702117,93975,17981,182
       Short-term Debt 
0
0
0
0
0
10,899
1,381
5,125
53,605
21,755
107,264
173,116
157,079
169,447
151,192
59,100
59,100151,192169,447157,079173,116107,26421,75553,6055,1251,38110,89900000
       Short Long Term Debt 
0
0
0
0
0
0
1,381
5,125
57,029
21,755
107,264
172,095
151,351
167,064
149,222
56,635
56,635149,222167,064151,351172,095107,26421,75557,0295,1251,381000000
       Accounts payable 
68,319
62,322
97,605
73,187
72,420
128,546
122,953
190,669
165,437
183,640
264,955
271,394
260,661
309,529
280,001
233,704
233,704280,001309,529260,661271,394264,955183,640165,437190,669122,953128,54672,42073,18797,60562,32268,319
       Other Current Liabilities 
12,770
12,816
20,300
54,378
60,851
103,711
135,101
21,578
18,111
42,850
19,336
27,180
197,330
12,611
21,794
11,444
11,44421,79412,611197,33027,18019,33642,85018,11121,578135,101103,71160,85154,37820,30012,81612,770
   > Long-term Liabilities 
123,522
160,641
118,209
86,662
12,127
19,372
22,037
19,907
25,652
142,607
183,427
153,392
136,489
192,147
127,126
26,228
26,228127,126192,147136,489153,392183,427142,60725,65219,90722,03719,37212,12786,662118,209160,641123,522
       Long term Debt Total 
0
0
0
0
0
0
0
0
3,424
107,259
166,300
138,639
119,284
144,400
101,393
6,022
6,022101,393144,400119,284138,639166,300107,2593,42400000000
       Other Liabilities 
0
0
0
0
0
0
22,037
19,907
22,227
8,664
10,841
14,753
17,204
47,747
25,733
20,205
20,20525,73347,74717,20414,75310,8418,66422,22719,90722,037000000
       Deferred Long Term Liability 
0
0
0
0
0
0
32,860
0
0
0
0
0
0
0
0
0
00000000032,860000000
> Total Stockholder Equity
49,111
85,368
136,419
194,273
912,632
1,054,071
1,122,907
1,114,168
1,220,499
1,240,066
1,144,722
1,051,506
984,159
791,484
630,508
739,532
739,532630,508791,484984,1591,051,5061,144,7221,240,0661,220,4991,114,1681,122,9071,054,071912,632194,273136,41985,36849,111
   Common Stock
6,335
26,168
46,840
98,864
161,864
161,864
161,864
161,864
161,864
161,864
161,864
161,864
247,028
247,028
247,028
247,028
247,028247,028247,028247,028161,864161,864161,864161,864161,864161,864161,864161,86498,86446,84026,1686,335
   Retained Earnings 
42,776
53,411
84,459
90,288
178,647
320,086
392,481
418,164
524,495
544,062
447,620
299,566
55,268
-138,487
-300,363
-191,008
-191,008-300,363-138,48755,268299,566447,620544,062524,495418,164392,481320,086178,64790,28884,45953,41142,776
   Accumulated Other Comprehensive Income 
-6,939
-11,309
-16,412
-22,443
-29,005
-37,145
-45,239
-56,527
-66,840
-83,560
-80,975
-145,240
-194,343
2,940
3,840
3,510
3,5103,8402,940-194,343-145,240-80,975-83,560-66,840-56,527-45,239-37,145-29,005-22,443-16,412-11,309-6,939
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
680,003
680,003
680,003680,00300000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
6,939
17,098
21,533
27,563
601,126
609,265
613,801
590,667
600,980
617,700
616,213
735,316
-302,296
-108,541
680,003
-56,020
-56,020680,003-108,541-302,296735,316616,213617,700600,980590,667613,801609,265601,12627,56321,53317,0986,939



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue632,046
Cost of Revenue-506,022
Gross Profit126,024126,024
 
Operating Income (+$)
Gross Profit126,024
Operating Expense-460,475
Operating Income-334,021-334,451
 
Operating Expense (+$)
Research Development0
Selling General Administrative100,882
Selling And Marketing Expenses3,431
Operating Expense460,475104,313
 
Net Interest Income (+$)
Interest Income54,931
Interest Expense-21,832
Other Finance Cost-54,931
Net Interest Income-21,832
 
Pretax Income (+$)
Operating Income-334,021
Net Interest Income-21,832
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-383,782-284,260
EBIT - interestExpense = -387,349
-282,242
-187,170
Interest Expense21,832
Earnings Before Interest and Taxes (EBIT)-365,517-361,950
Earnings Before Interest and Taxes (EBITDA)-295,249
 
After tax Income (+$)
Income Before Tax-383,782
Tax Provision--73,240
Net Income From Continuing Ops-310,542-310,542
Net Income-209,002
Net Income Applicable To Common Shares-209,002
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses966,497
Total Other Income/Expenses Net-49,76121,832
 

Technical Analysis of Brooks Laboratories Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Brooks Laboratories Limited. The general trend of Brooks Laboratories Limited is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Brooks Laboratories Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Brooks Laboratories Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 116.00 < 139.30 < 140.00.

The bearish price targets are: 92.00 > 91.25 > 87.10.

Tweet this
Brooks Laboratories Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Brooks Laboratories Limited. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Brooks Laboratories Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Brooks Laboratories Limited. The current macd is -2.37936594.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Brooks Laboratories Limited price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Brooks Laboratories Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Brooks Laboratories Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Brooks Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) ChartBrooks Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Brooks Laboratories Limited. The current adx is 16.30.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Brooks Laboratories Limited shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Brooks Laboratories Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Brooks Laboratories Limited. The current sar is 96.78.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Brooks Laboratories Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Brooks Laboratories Limited. The current rsi is 48.24. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Brooks Laboratories Limited Daily Relative Strength Index (RSI) ChartBrooks Laboratories Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Brooks Laboratories Limited. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Brooks Laboratories Limited price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Brooks Laboratories Limited Daily Stochastic Oscillator ChartBrooks Laboratories Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Brooks Laboratories Limited. The current cci is 22.50.

Brooks Laboratories Limited Daily Commodity Channel Index (CCI) ChartBrooks Laboratories Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Brooks Laboratories Limited. The current cmo is 4.34341809.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Brooks Laboratories Limited Daily Chande Momentum Oscillator (CMO) ChartBrooks Laboratories Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Brooks Laboratories Limited. The current willr is -65.11627907.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Brooks Laboratories Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Brooks Laboratories Limited Daily Williams %R ChartBrooks Laboratories Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Brooks Laboratories Limited.

Brooks Laboratories Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Brooks Laboratories Limited. The current atr is 4.0855251.

Brooks Laboratories Limited Daily Average True Range (ATR) ChartBrooks Laboratories Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Brooks Laboratories Limited. The current obv is 4,646,195.

Brooks Laboratories Limited Daily On-Balance Volume (OBV) ChartBrooks Laboratories Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Brooks Laboratories Limited. The current mfi is 87.70.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Brooks Laboratories Limited Daily Money Flow Index (MFI) ChartBrooks Laboratories Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Brooks Laboratories Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Brooks Laboratories Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Brooks Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.235
Ma 20Greater thanMa 50103.315
Ma 50Greater thanMa 100111.745
Ma 100Greater thanMa 200127.479
OpenGreater thanClose104.800
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Brooks Laboratories Limited with someone you think should read this too:
  • Are you bullish or bearish on Brooks Laboratories Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Brooks Laboratories Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Brooks Laboratories Limited

I send you an email if I find something interesting about Brooks Laboratories Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Brooks Laboratories Limited.

Receive notifications about Brooks Laboratories Limited in your mailbox!